JQKD-82

N/A

Report date: 2023/12/18 18:08:20
NME

Base Information

Drug NameJQKD-82
Drug Alias NameJQKD-82
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysine-specific demethylase 5A inhibitors
TargetsLysine-specific demethylase 5A
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDana-Farber Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesDana-Farber Cancer Institute
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A